Barclays PLC Phasebio Pharmaceuticals Inc C Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
N/A
-31,698 Reduced 99.38%
197 $0
Q1 2022

May 16, 2022
BUY
N/A
2,181 Added 7.34%
31,895 $43,000
Q4 2021

Feb 14, 2022
SELL
N/A
-2,909 Reduced 8.92%
29,714 $78,000
Q3 2021

Nov 09, 2021
SELL
N/A
-1,147 Reduced 3.4%
32,623 $101,000
Q2 2021

Aug 13, 2021
BUY
N/A
21,016 Added 164.78%
33,770 $126,000
Q1 2021

May 13, 2021
BUY
N/A
7,831 Added 159.07%
12,754 $45,000
Q4 2020

Feb 11, 2021
SELL
N/A
-5,427 Reduced 52.43%
4,923 $16,000
Q3 2020

Nov 12, 2020
SELL
N/A
-7,175 Reduced 40.94%
10,350 $36,000
Q2 2020

Aug 12, 2020
BUY
N/A
6,890 Added 64.79%
17,525 $80,000
Q1 2020

May 13, 2020
SELL
N/A
-11,334 Reduced 51.59%
10,635 $35,000
Q4 2019

Feb 10, 2020
BUY
N/A
6,403 Added 41.13%
21,969 $134,000
Q3 2019

Nov 14, 2019
SELL
N/A
-10,692 Reduced 40.72%
15,566 $65,000
Q2 2019

Aug 14, 2019
BUY
N/A
19,958 Added 316.79%
26,258 $344,000
Q1 2019

May 15, 2019
BUY
N/A
6,300 New
6,300 $60,000

About PHASEBIO PHARMACEUTICALS INC C

PHASQ Quotes by TradingView
  • Ticker PHASQ
More about PHASQ
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email